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Numerous epidemiologic studies have
reported associations between exposure to
ambient levels of particulate matter (PM) and
various indices of acute cardiopulmonary
morbidity and mortality [U.S. Environmental
Protection Agency (EPA) 2004]. Ambient
PM exposure at current levels has been impli-
cated in the onset and exacerbation of lung
and heart disease (U.S. EPA 2004). Although
the primary mode of entry into the body is
through the respiratory system, the greatest
population-attributable risk from air pollu-
tion is due to cardiovascular disease.
Epidemiologic data suggest that individu-
als with diabetes may be at higher risk from
effects of PM (O’Neill et al. 2007; Zanobetti
and Schwartz 2001, 2002). Several parallels
exist between the pathophysiologic effects of
diabetes and the cardiovascular, hematologic,
and autonomic responses to airborne PM.
Moreover, evidence indicates that diabetes
and insulin resistance are associated with
endothelial dysfunction (Caballero 2003;
Feener and King 2001; Hsueh and Quinones
2003; Schram et al. 2004), which suggests
that people with diabetes may be particularly
susceptible to the effects of PM.
Flow-mediated dilatation (FMD) of the
brachial artery is a noninvasive method of
assessing endothelial function that has been
widely employed in clinical studies of vascular
biology. The technique uses high-definition
ultrasound to measure brachial artery diame-
ter before and after an increase in shear stress
that is induced by reactive hyperemia. The
arterial dilatation, quantified as the percent
change in arterial diameter, reflects local
endothelial release of nitric oxide (NO). This
endothelial-dependent response to increased
shear stress can be contrasted to the endothe-
lium-independent dilatation observed with
nitroglycerin. As an index of endothelial func-
tion, FMD can be viewed as a “barometer” of
vascular health and is considered a reasonable
surrogate marker for assessing atherosclerosis
(Perticone et al. 2001; Sorensen et al. 1997).
Endothelial dysfunction plays a signiﬁcant
role in the atherosclerotic process (Bonetti
et al. 2003; Libby et al. 2002). Impaired func-
tion of the vascular endothelium is associated
with a number of vascular changes, such as
decreased vasodilatation, development of pro-
thrombotic and proinﬂammatory states, and
smooth muscle cell proliferation, all of which
contribute to the formation and progression
of chronic atherosclerotic lesions (Widlansky
et al. 2003). An increased incidence of adverse
cardiovascular events has been reported in
subjects with impaired endothelial function
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BACKGROUND: Exposure to fine airborne particulate matter [≤ 2.5 µm in aerodynamic diameter
(PM2.5)] has been associated with cardiovascular and hematologic effects, especially in older people
with cardiovascular disease. Some epidemiologic studies suggest that adults with diabetes also may
be a particularly susceptible population.
OBJECTIVES: The purpose of this study was to analyze the short-term effects of ambient PM2.5 on
markers of endothelial function in diabetic volunteers.
METHODS: We conducted a prospective panel study in 22 people with type 2 diabetes mellitus in
Chapel Hill, North Carolina (USA), from November 2004 to December 2005. We acquired daily
measurements of PM2.5 and meteorologic data at central monitoring sites. On 4 consecutive days,
we measured endothelial function by brachial artery ultrasound in all participants and by pulsewave
measurements in a subgroup. Data were analyzed using additive mixed models with a random par-
ticipant effect and adjusted for season, day of the week, and meteorology.
RESULTS: Flow-mediated dilatation decreased in association with PM2.5 during the first 24 hr,
whereas small-artery elasticity index decreased with a delay of 1 and 3 days. These PM2.5-associated
decrements in endothelial function were greater among participants with a high body mass index,
high glycosylated hemoglobin A1c, low adiponectin, or the null polymorphism of glutathione
S-transferase M1. However, high levels of myeloperoxidase on the examination day led to strongest
effects on endothelial dysfunction.
CONCLUSIONS: These data demonstrate that PM2.5 exposure may cause immediate endothelial dys-
function. Clinical characteristics associated with insulin resistance were associated with enhanced
effects of PM on endothelial function. In addition, participants with greater oxidative potential
seem to be more susceptible.
KEY WORDS: air pollution, diabetes, endothelial dysfunction, environmental epidemiology, particu-
late matter. Environ Health Perspect 116:1666–1674 (2008). doi:10.1289/ehp.11666 available via
http://dx.doi.org/ [Online 31 July 2008]compared with subjects with preserved
endothelial function (Gokce et al. 2002, 2003;
Heitzer et al. 2001; Perticone et al. 2001).
Therefore, endothelial dysfunction as a reac-
tion to increased ambient PM might provide
further mechanistic insight into the observed
associations between PM exposure and
increased morbidity and mortality. Several
previous studies have suggested that exposure
to air pollutants results in endothelial dysfunc-
tion (Briet et al. 2007; Brook et al. 2002;
O’Neill et al. 2005) in healthy volunteers.
We conducted this study to examine the
effects of fluctuations in ambient PM expo-
sure, measured at a local air monitoring sta-
tion, on changes in endothelial function
parameters among adults with type 2 dia-
betes. We hypothesized that exposure to
increased ambient air pollutants results in fur-
ther impairment of endothelial function.
Moreover, we analyzed effect modiﬁcation by
clinical characteristics associated with insulin
resistance such as body mass index (BMI),
glycosylated hemoglobin A1c (HbA1c), and
adiponectin and by daily myeloperoxidase
(MPO) level. MPO is an enzyme that binds
to the vessel wall, critically modulates struc-
tural and humoral integrity of the vessel wall,
and depletes vascular NO bioavailability
(Eiserich et al. 2002; Nicholls and Hazen
2005; Rudolph et al. 2006).
To identify susceptible subgroups, we also
analyzed effect modification by genes of the
antioxidant defense family and the hemochro-
matosis gene (HFE). The protein product of
the HFE gene modulates iron binding and
storage (Hanson et al. 2001) from pulmonary
sources. The analyzed polymorphisms are
associated with increased iron uptake (Feder
et al. 1998) and may modify the toxic effect of
metal-rich PM on the cardiovascular system
because iron stores are inversely associated
with the gastrointestinal absorption of poten-
tially toxic metals (Flanagan et al. 1980).
Materials and Methods
Study population. We identified 22 volun-
teers, 48–80 years of age, with type 2 diabetes
through the University of North Carolina–
Chapel Hill (UNC) Diabetes and General
Medicine Clinics and through newspaper
advertisements. Potential participants had to
meet the following inclusion criteria: a)a
diagnosis of type 2 diabetes, but without tak-
ing insulin; b) a stable medication regimen
throughout their participation; and c) an elec-
trocardiogram demonstrating normal sinus
rhythm. We excluded potential participants
for any of the following criteria: a) a current
smoker or a smoking history, deﬁned as more
than one pack of cigarettes within the year
before enrollment; b) a hematocrit < 36%;
c) a medical history or health problems that
preclude participation, as decided by the
study physician, such as presence of a pace-
maker or implanted cardioverter deﬁbrillator,
history of atrial fibrillation, history of solid
organ transplant, dialysis therapy, active can-
cer or history of cancer within the last 5 years,
hepatitis B or C, unstable angina, hypersensi-
tivity to nitroglycerin/nitrates/nitrites, or res-
piratory tract infection within the preceding
4 weeks; d) a recent vascular event or interven-
tion (< 6 months or < 1 year ago, depending on
the type of intervention), such as coronary
artery graft bypass surgery or percutaneous
coronary intervention; or e) pregnancy.
Participants were asked to refrain from vigorous
exercise on study mornings and to refrain from
taking antioxidants (e.g., vitamins C and E),
fish oil, niacin, arginine, over-the-counter
vasoactive agents (e.g., decongestants), and anti-
inﬂammatory agents (e.g., ibuprofen, naproxen,
aspirin) unless it was prescribed as a daily medi-
cation (in which case it was continued), for the
week before the study as well as the week of
the study. Participants were also asked to
refrain from use of phosphodiesterase enzyme
inhibitors during the week of the study.
Each participant visited the U.S. EPA
Human Studies Facility (HSF) in Chapel Hill,
North Carolina, on 5 consecutive weekdays
between November 2004 and December
2005. We obtained data on health status, pul-
monary and cardiac symptoms, medication,
and smoking history at baseline and during
four follow-up visits. Altogether, a maximum
of 88 observations were available for analysis,
depending on the examined health outcome.
All volunteers signed a written consent form,
and the study protocol was approved by the
UNC Human Studies Biomedical Institutional
Review Board and by the U.S. EPA.
Clinical measurements. Clinical proce-
dures. On Monday morning of each examina-
tion week, the participants ﬁlled out a baseline
questionnaire. In each of the next four morn-
ings, participants checked into the medical sta-
tion under fasting conditions and without
having taken their antidiabetic medication.
Upon ﬁrst arriving at the medical station each
morning, a glucometer was used to evaluate
fasting glucose levels.
A blood sample was obtained from each
participant at each visit and analyzed by a clini-
cal laboratory (Lab Corp., Burlington, NC,
USA) for a full blood panel, including
adiponectin, homocysteine, and HbA1c. MPO
was detected using a Human Cardiovascular
Disease Panel (Lincoplex, Linco Research, Inc.,
St. Charles, MO, USA) run on a Luminex 100
Multiplex system. MPO, homocysteine, and
adiponectin were measured during each visit,
whereas HbA1c was measured only once. In
addition, DNA analysis was performed with
regard for the null polymorphism of glu-
tathione S-transferase M1 (GSTM1) (chromo-
somal location 1p13.3), the valine-coding
polymorphism (Ile105Val) of GSTP1 (chro-
mosomal location 11q13), the aspartic acid-
coding polymorphism H63D (His63Asp) of
the HFE gene (chromosomal location 6p21.3),
the tyrosine-coding polymorphism C282Y
(Cys282Tyr) of the HFE gene, and the serine-
coding polymorphism P149S (Pro149Ser) of
the quinone oxidoreductase (NQ01) gene
(chromosomal location 16q22.1).
Participants were then escorted to the
UNC General Clinical Research Center, where
vascular reactivity was assessed by measuring
flow-mediated and nitroglycerin-mediated
dilatation (NTGMD) of the brachial artery
via ultrasound. In 13 participants, pulse wave-
form measurements were performed to obtain
a measure of arterial stiffness. Soon after the
measurements were completed, participants
took their antidiabetic medication together
with a diabetic snack.
Endothelial function and vascular compli-
ance measurements. We measured FMD and
NTGMD of the brachial artery using an HDI
5000 ATL ultrasound machine equipped with
a 12.5-MHz transducer (Philips, Bothell, WA,
USA) according to the guidelines published by
Corretti et al. (2002). A resting blood pressure
was measured at baseline. Images of the right
brachial artery were then acquired at rest and
during reactive hyperemia for quantification
of FMD. After baseline images were recorded,
hyperemia was induced by inflating a pneu-
matic tourniquet proximal to the brachial
artery to 50 mmHg above systolic pressure for
5 min. Images of the brachial artery were
acquired for 90 sec after abrupt cuff deﬂation.
NTGMD was then assessed. A second base-
line image was acquired after 15 min of rest,
and a final image was then recorded 5 min
after administration of 400 µg sublingual
nitroglycerin spray.
Gated end-diastolic images of the brachial
artery were stored in a digital format for subse-
quent analysis. We measured arterial diameter
from the lumen–intimal interfaces of the prox-
imal and distal walls using customized soft-
ware (Brachial Tools, Medical Imaging
Applications, LLC, Coralville, IA, USA). Data
from at least three consecutive end-diastolic
frames were averaged for each baseline mea-
surement, and from at least three frames at
maximal dilatation during reactive hyperemia
and after administration of nitroglycerin.
FMD and NTGMD were calculated as the
percentage change in vessel diameter from
their respective baselines. FMD is a measure of
endothelial-dependent vasomotion and is due
largely to endothelial release of NO, whereas
the endothelium-independent dilatation
observed in response to nitroglycerin reﬂects
vascular reactivity to an exogenous NO donor.
We assessed vascular compliance (arterial
elasticity) by the contour analysis of the arterial
pressure waveform (pulsewave) using the
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vascular Profiling System (Hypertension
Diagnostics, Inc., Eagan, MN, USA).
According to the method described by Cohn
et al. (1995), a blood-pressure cuff was placed
around the participant’s left upper arm and a
stabilizer was placed on the participant’s right
wrist for optimal positioning and minimal
movement during data collection. After palpat-
ing the strongest radial pulsation, we placed a
piezoelectric sensor perpendicular to the skin
overlying the right radial artery to capture an
analog blood pressure waveform data signal.
The tonometer sensor array adjusts automati-
cally until it obtains stable waveform. We then
obtained three assessments of arterial compli-
ance and averaged them for analyses. The sys-
tem determined capacitive compliance of the
proximal aorta and major branches [large-
artery elasticity index (LAEI)], sinusoidal oscil-
latory compliance of the distal arteries
[small-artery elasticity index (SAEI)], and sys-
temic vascular resistance (SVR), all indirect
measures of endothelial function. Endothelial
dysfunction can be associated with decreasing
elasticity indices and an increase in SVR. Using
a noninvasive, direct acoustic transducer, the
system gathered and analyzed a 30-sec analog
tracing of the radial artery waveforms digitized
at 200 samples/sec. A beat determination was
made during that 30-sec period determining
systole, peak systole, onset of diastole, and end
of diastole. Representative averaged waveforms
of individual beats were analyzed using a para-
meter-estimating algorithm (Finkelstein and
Cohn 1992) to ﬁt a multiexponential model
based on the Windkessel model for identifying
the three pulse waveform indices (O’Rourke
and Gallagher 1996).
Air pollution monitoring. We obtained
daily 24-hr concentrations (midnight to
midnight) of official ambient PM2.5 (PM
≤ 2.5 µm in aerodynamic diameter) mass net-
work data from a monitoring station located
approximately 44 km (27 miles) east of the
HSF. In addition, we measured concentrations
of ambient PM2.5 mass (0900–0900 hours)
with a 3000K Versatile Air Pollution Sampler
(URG Corp., Chapel Hill, NC, USA)
(Williams et al. 2000) located on the HSF
rooftop approximately 30 m above ground
level. The Spearman correlation between both
PM2.5 measurements was 0.85, and the rooftop
data was used to impute 3 days of missing net-
work data based on a linear regression model.
We obtained continuous 2-min measure-
ments of air temperature, barometric pres-
sure, and relative humidity from the HSF
rooftop and calculated 24-hr averages if 240
(33%) or fewer 2-min values were missing on
any day. The rooftop data were complete, so
no imputation was necessary.
Statistical analyses. The study was con-
ducted as a panel study with four repeated
measurements per participant. Thus, every
person acted as his or her own control, which
limited the need for an adjustment for patient
characteristics in the analysis.
We analyzed data using the SAS, version
9.1, statistical package (SAS Institute, Inc.,
Cary, NC, USA). For the analysis of the PM
effect, we used additive mixed models with a
random participant effect and “compound
symmetry” covariance structure (Greven et al.
2006). We built models to identify meteoro-
logic and temporal determinants as potential
confounders, for each outcome variable sepa-
rately. We assessed model fit by the Akaike
Information Criterion (AIC). In a ﬁrst selection
step, we considered air temperature, relative
humidity, and barometric pressure as potential
confounders of the association between health
parameters and network PM2.5. For all three
meteorologic parameters, we checked individ-
ual lags at lag 0 to lag 4 and the 5-day moving-
average as possible determinants—either linear
or as penalized smoothing splines with a maxi-
mum of 20 knots. After the selection of meteo-
rology, we examined day of week and season as
determinants. We defined season as “cold”
from 19 November 2004 to 31 March 2005
and from 1 November 2005 to 9 December
2005, and as “warm” from 1 April 2005 to
31 October 2005. None of the above determi-
nants were selected for the model if the AIC
showed no improvement in model ﬁt.
We considered the exposure, in this case
ambient PM2.5 mass, as an immediate (lag 0),
a delayed (lag 1 to lag 4), or a cumulative lin-
ear effect over 5 days. We present effect esti-
mates as percent changes of the mean
outcome variable together with 95% confi-
dence intervals (CIs) for a 10-µg/m3 incre-
ment in ambient PM2.5 mass.
We analyzed sensitivity by changing the
covariance structure to first-order auto-
correlation. Moreover, for signiﬁcant results,
we applied a model with random slopes for the
PM effect to assess the individual responses of
the participants.
We performed effect modiﬁcation analy-
ses using dichotomous indicator variables and
an interaction term. We considered the inﬂu-
ence of BMI (cut point, 30 kg/m2), HbA1c
(cut point, 7%), adiponectin (cut point,
3,700 ng/mL), homocysteine (cut point,
12 µmol/L), MPO (cut point, 7 ng/mL), and
statin intake (yes/no). Cut points were typi-
cally near the median value seen in the 22 par-
ticipants. In addition, we assessed gene–
environment interaction analyses for the poly-
morphisms of GSTM1, GSTP1, HFE H63D,
HFE C282Y, and NQ01 P149S. Because we
assessed only 13 participants for pulse wave-
form response, the sample size was too small
to analyze the potential effect modiﬁcation of
GSTP1, HFE, or NQ01.
Results
Participant characteristics. The participants
were 48–78 years of age, and their BMIs were
20–44 kg/m2. Almost two-thirds of the
recruited volunteers were male (Table 1). All
participants were current nonsmokers, but
almost half of them were ex-smokers. About
half of the participants were obese, and < 50%
had a systolic blood pressure > 140 mmHg,
indicating mild hypertension. Duration of
type 2 diabetes ranged from 2 months to
23 years (Table 2). Most participants had a
history of hypertension and dyslipidemia.
Almost one-third of the participants had a
combination of elevated HbA1c, elevated
homocysteine, and low adiponectin values.
Most participants were being treated with
oral antihyperglycemic medications such as
Schneider et al.
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Table 1. Description of the study population characteristics: current nonsmoking subjects with type 2
diabetes mellitus.
Characteristic All subjects (n = 22) Pulse waveform subjects (n = 13)
Age (years) 61 ± 8 59 ± 6
Male sex 14 (64) 7 (54)
Ethnicity
Caucasian 15 (68) 7 (54)
African American 6 (27) 6 (46)
Hispanic American 1 (5) 0 (0)
BMI (kg/m2) 33 ± 7 34 ± 7
≥ 30 kg/m2 12 (55) 7 (54)
Average systolic blood pressure ≥ 140 mmHg 9 (41) 6 (46)
Smoking
Never-smoker 12 (55) 8 (62)
Ex-smoker 10 (45) 5 (38)
Null polymorphism of GSTM1 10 (45)a 5 (38)b
Valine-coding polymorphism of GSTP1 10 (45)c —d
Aspartic acid–coding polymorphism H63D of HFE gene 4  (18)e —d
Tyrosine-coding polymorphism C282Y of HFE gene 1  (5)f —d
Serine-coding polymorphism P149S of NQ01 gene 4  (18)g —d
Values shown are mean ± SD or no. (%). 
aFour subjects declined permission for genetic testing. bTwo subjects declined permission for genetic testing. cTwo (9%)
subjects were homozygous for the minor allele. dSample size was too small for stratiﬁcation on genotype. eNo subjects
were homozygous for the minor allele. fNo subjects were homozygous for the minor allele. gOne (5%) subject was
homozygous for the minor allele.metformin, sulfanylureas, and thiazolidine-
diones, and half of them were taking statins
and antihypertensives. About two-thirds of
the participants regularly took aspirin.
Description of vascular measures. The aver-
age values of the vascular measures were typical,
with a 5.9% increase in brachial artery diameter
after reactive hyperemia and a 13.4% increase
in diameter after administration of nitroglycerin
(Table 3). Responses to reactive hyperemia and
nitroglycerin were independent, showing a
median within-patient Spearman correlation of
0.09. Of the 13 volunteers with additional
pulse waveform measurements, one had to be
excluded as an overly inﬂuential outlier for the
SAEI analysis because he showed extremely
high values compared with the range of all
other observations. We therefore analyzed the
association for SAEI and PM2.5 only among the
remaining 12 participants. Correlations
between FMD and the three pulse waveform
measurements LAEI, SAEI, and SVR were very
weak, with correlation coefficients of 0.19,
–0.17, and 0.36, respectively.
Air pollutant and meteorology measure-
ments. The 24-hr PM2.5 values over the study
period were generally below the U.S. National
Ambient Air Quality Standard (NAAQS) of
35 µg/m3 (U.S. EPA 2006), and the mean
over the study period was less than the annual
average NAAQS of 15 µg/m3 (Table 3).
Participant visits were fairly uniformly distrib-
uted over the study period (Figure 1A). Air
temperature (Figure 1B) showed the expected
seasonal variation, whereas the PM2.5 concen-
trations (Figure 1C) showed mostly daily vari-
ations with little seasonal pattern. Median
within-patient Spearman correlation can be
found in the Supplemental Material, Table 1
(http://www.ehponline.org/members/
2008/11666/suppl.pdf).
Association between air pollution and vas-
cular parameters. FMD was signiﬁcantly asso-
ciated with PM2.5 levels on the same day
(lag 0), suggesting that endothelial dysfunction
is a relatively rapid consequence of exposure to
PM (Table 4). The estimates given in Table 4
correspond to an absolute mean change in
FMD (lag 0) per 10-µg/m3 increase in PM2.5
of –1.0% (95% CI, –2.0 to 0.0). There was no
signiﬁcant association of NTGMD with PM2.5
on the same day, suggesting that the decrease
in FMD with increased PM2.5 is endothelium
dependent and does not reflect increased
smooth muscle cell reactivity. There was, how-
ever, a decrease in NTGMD with a lag of
1 day, suggesting the possibility of an impair-
ment of smooth muscle cell responsivity to
nitroglycerin with a slight delay. SAEI
decreased significantly with a lag of 1 and
3 days and also with the 5-day average, whereas
SVR increased after 2 and 4 days. Similar to
SAEI, LAEI decreased in association with
PM2.5 with a lag of 3 days (Table 4).
The participant-speciﬁc changes in FMD
and SAEI were quite homogeneous for all the
participants (p-values for heterogeneity were
not signiﬁcant), suggesting that the response
was not driven by a small subset of individu-
als [see Supplemental Material, Figure 1
(http://www.ehponline.org/members/2008/
11666/suppl.pdf)]. The signiﬁcant association
of PM and SAEI at lag 3 was sensitive to the
exclusion of the inﬂuential outlier.
The estimated effects were not sensitive to
changing the covariance matrix from com-
pound symmetry to ﬁrst-order autocorrelation.
Effect modiﬁcation analysis. Diabetes is a
heterogeneous disorder with regard to disease
severity, disease control, and medication
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Table 2. Description of the study population clinical characteristics: current nonsmoking subjects with
type 2 diabetes mellitus.
Characteristic All subjects (n = 22) Pulse waveform subjects (n = 13)
Disease history
Type 2 diabetes mellitus  22 (100) 13 (100)
Time since diabetes diagnosis (years) 6.4 ± 5.0 6.3 ± 6.0
Hyperlipidemia 19 (86) 11 (85)
Hypertension 19 (86) 11 (85)
Past myocardial infarction 0 (0) 0 (0)
Coronary artery disease 4 (18) 1 (8)
Peripheral vascular disease 3 (14) 1 (8)
Cerebrovascular disease 1 (5) 0 (0)
Diabetic retinopathy 1 (5) 0 (0)
Diabetic nephropathya 8 (36) 7 (54)
Blood marker levels
HbA1cb 6.7 ± 0.9
≥ 7%b 9 (41)c 6 (46)
Homocysteineb 12.9 ± 3.4
≥ 12 μmol/Lb 11 (50)c 7 (54)d
Adiponectinb 4,727 ± 4,067
< 3,700 ng/mLb 11 (50)d 7 (54)
MPOb 9.8 ± 7.3
≥ 7 ng/mLb 41 (51) 24 (47)
Medication use
Sulfonylureas 10 (45) 6 (46)
Thiazolidinediones 6 (27) 2 (15)
Metformin 14 (64) 10 (77)
Statins 12 (55) 7 (54)
Aspirin 14 (64) 9 (69)
Beta-blockers 9 (41) 4 (31)
Angiotensin-converting enzyme inhibitors 12 (55) 8 (62)
Calcium blockers 2 (9) 1 (8)
Diuretics 8 (36) 6 (46)
Angiotension II receptor blocker 3 (14) 2 (15)
Estrogen 2 (9) 2 (15)
Values shown are mean ± SD or no. (%). 
aBased on the screening urine ( > 30 μg albumin/mg creatinine) on spot collection. bHbA1c was measured only once, but
homocysteine, adiponectin, and MPO were measured on all four visits. For the interaction analysis, we used the mean of
the four measurements per subject for homocysteine and adiponectin. For MPO, we used all observations per patient
because it showed high daily variation within subjects. cData were missing from two subjects. dData were missing from
one subject.
Table 3. Description of health parameters, PM2.5, and meteorology.
Parameter No. Mean ± SD Minimum Maximum
Endothelial function parameters
Brachial artery ultrasound
Brachial artery diameter at baseline (mm)a 84 3.96 ± 0.65 2.91 5.98
FMD (%)a 83 5.9 ± 3.9 0.4 16.3
NTGMD (%)a 78 13.4 ± 7.4 3.8 32.1
Pulse waveform
LAEI (mL/mmHg × 10)b 51 16.5 ± 3.6 12.4 22.4
SAEI (mL/mmHg × 100)b 47 4.2 ± 1.6 1.7 7.1
SVR (dyne sec/cm5)b 51 1415.0 ± 244.0 959.6 1702.5
Network PM2.5
PM2.5 (μg/m3)  383 13.6 ± 7.0 2.0 38.9
HSF rooftop meteorology
Air temperature (°C) 385 15.9 ± 8.5 –6.5 31.5
Relative humidity (%) 385 62.5 ± 16.6 25.1 97.7
Barometric pressure (hPa) 386 1001.2 ± 6.5 981.4 1021.9
aBrachial artery ultrasound values are the mean from the patient mean of four measurements from 22 subjects. bPulse wave-
form values are the mean from the patient mean of four measurements of 13 patients; one patient was excluded for the SAEI
because of extremely high values.use. Among the diabetic participants, PM2.5-
associated changes in FMD were modiﬁed by
several of such clinical characteristics associated
with insulin resistance (Figure 2). Participants
with high BMI tended to have a greater
response to PM2.5. Individuals with, on aver-
age, high HbA1c, low plasma adiponectin, or
high homocysteine and participants not treated
with statins also showed increased responsive-
ness. However, interaction terms were statisti-
cally significant only for MPO. Individuals
with elevated MPO levels on the examination
day had greater impairment of FMD in associ-
ation with PM2.5 than did individuals with low
MPO levels on that day. Interestingly, in the
subgroup with high MPO levels, the signifi-
cant decrease in FMD remained also for lag 1
and lag 2.
With regard to gene–environment inter-
action analysis, we detected a clear effect
modification by the GSTM1 null polymor-
phism (deletion on both alleles) for FMD
(lag 0). We found a similar association for
SAEI with lag 1 (Figure 3). For GSTP1, we
examined the wild type and a variant in
which isoleucine is replaced by valine. We
assessed dominant, recessive, and additive
models to examine GSTP1 gene–environment
interactions, and an additive model proved to
be the best choice. With each copy of the
valine-coding allele for GSTP1, the PM2.5-
associated decrement in FMD (lag 0) showed
an interesting, but not statistically signiﬁcant,
trend: –12.5% (95% CI, –45.0 to 20.1) for
the wild type, –18.2% (95% CI, –37.6 to
1.2) for one copy of the valine-coding
allele, and –23.9% (95% CI, –56.3 to 8.4)
for two copies. 
The interaction with the HFE polymor-
phism HFE H63D (wild-type coding for his-
tidine to variant coding for aspartic acid)
could be analyzed only with a dominant
model because only 4 of the 22 participants
had this variant, and none of them was
homozygous. The participants with wild type
showed a PM2.5–associated decrement (not
statistically significant) in FMD (lag 0) of
–15.0% (95% CI, –37.7 to 7.7), whereas the
four participants with one copy of the variant
showed –30.1% (95% CI, –70.9 to 10.7). 
Because of small sample numbers, we did
not observe statistically signiﬁcant interactions
with other analyzed gene polymorphisms
(HFE C282Y and NQ01 P149S).
Discussion
We analyzed markers of endothelial function
in diabetes type 2 participants in association
with day-to-day changes of PM2.5 in a
repeated measurement framework. We found
FMD of the brachial artery to be decreased
on the same day with increasing ambient
PM2.5 exposure.
Endothelial function in general. The
endothelium is composed of cells that not
only serve as a physical barrier between blood
and tissues but also act to maintain vascular
homeostasis, the dynamic balance between
vasodilatation and vasoconstriction, by synthe-
sizing and releasing substances that modulate
vascular tone and structure. In addition, it
plays an important role in the interaction of
circulating cells with the vessel wall. It inhibits
and stimulates smooth muscle cell prolifera-
tion and migration and takes part in processes
of thrombosis and ﬁbrinolysis (Cohen 2007;
Mahmoudi et al. 2007). Endothelial dysfunc-
tion is uniformly recognized to be character-
ized by loss of normal endothelium-dependent
vasodilatation (Mahmoudi et al. 2007).
Impaired endothelial function is associated
with nearly all known cardiovascular risk fac-
tors (Celermajer et al. 1994; Ganz and Vita
2003; Libby et al. 2002; Ross 1999; Vita and
Keaney 2002) and is predictive of future car-
diovascular events (Gokce et al. 2002, 2003;
Heitzer et al. 2001). It can be used to identify
individuals at risk before the development of
clinically apparent cardiovascular disease.
FMD, as an index of endothelial function,
represents an excellent measure of underlying
vascular health and reflects the combined
influence of the known and unknown
processes that contribute to atherosclerosis
(Kardasz and De Caterina 2007; Vita and
Keaney 2002; Widlansky et al. 2003). Because
endothelial dysfunction plays a central role in
the pathogenesis of cardiovascular disease, it
may underpin the link between air pollution
and the risk of an acute coronary event.
Endothelial cells mediate vasodilatation
predominantly through the production of
NO. NO diffuses into the underlying smooth
muscle cells, where it is responsible for smooth
muscle cell relaxation and vascular dilatation.
NO produced by endothelial cells also has
Schneider et al.
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Table 4. Percent change of mean endothelial function and vascular compliance parameters per 10-μg/m3 increase in PM2.5 [estimate (95% CI)].
PM2.5 days before clinical measurement FMD NTGMD LAEI SAEI SVR
Lag 0 –17.3 (–34.6 to 0.0)* 2.5 (–9.0 to 13.9) 0.4 (–4.2 to 5.0) –3.0 (–13.0 to 7.0) –1.6 (–3.7 to 0.4)
Lag 1 –4.4 (–24.6 to 15.8) –13.6 (–24.5 to –2.6)* –0.3 (–6.0 to 5.4) –17.0 (–27.5 to –6.4)** 1.6 (–0.9 to 4.1)
Lag 2 –18.6 (–44.8 to 7.6) –10.2 (–23.5 to 3.0) 2.5 (–4.3 to 9.4) –9.7 (–23.5 to 4.2) 3.5 (0.5 to 6.5)*
Lag 3 1.6 (–23.6 to 26.9) –8.0 (–22.4 to 6.4) –7.3 (–13.5 to –1.1)* –15.1 (–29.3 to –0.9)* 2.4 (–0.5 to 5.3)
Lag 4 18.4 (–3.5 to 40.3) 3.6 (–7.9 to 15.0) –2.3 (–8.0 to 3.3) –2.1 (–14.0 to 9.7) 3.2 (0.7 to 5.6)*
Five-day average –19.4 (–62.6 to 23.8) –19.4 (–44.3 to 5.5) –4.6 (–15.3 to 6.1) –25.4 (–45.4 to –5.3)* 4.5 (–0.3 to 9.2)
*p < 0.05. **p < 0.01. 
Figure 1. Patient visits, air temperature, and PM2.5 between 19 November 2004 and 9 December 2005. (A) Data
points represent the week each of the 22 participants visited the HSF. (B) Daily 24-hr temperature averages
(midnight to midnight) calculated from continuous 2-min data collected from the HSF rooftop. (C) Imputed
24-hr average PM2.5 concentrations (midnight to midnight) collected at the ofﬁcial network station.
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Canti-inflammatory effects, which include a
decrease in soluble vascular cell and intercellu-
lar adhesion molecules-1, E-selectin, and
tumor necrosis factor α (Hsueh et al. 2004).
Endothelial function in diabetes. Type 2
diabetes is characterized by insulin resistance.
The parallel progression between insulin resis-
tance and endothelial dysfunction suggests a
close relationship between the two (Hsueh
et al. 2004). Insulin stimulates NO produc-
tion from endothelial cells, so people with
diabetes usually have lower baseline levels of
NO than do subjects without diabetes
(Calles-Escandon and Cipolla 2001; Creager
et al. 2003; Quyyumi 1998).
Diabetes and PM. People with diabetes
have been shown to be at greater risk for mor-
bidity and mortality associated with exposure
to PM (Goldberg et al. 2006; Zanobetti and
Schwartz 2002). Although many people with
diabetes have secondary cardiovascular compli-
cations, as a group they show larger effect sizes
to PM than do people with cardiovascular dis-
ease and no diabetes (Zanobetti and Schwartz
2001). One possibility for the added respon-
siveness may be that people with diabetes have
endothelial dysfunction. If vascular endothelial
cells in these individuals are compromised,
they may be more susceptible to the effects of
PM. Additionally, people with diabetes are
known to have disproportional reactive oxygen
species formation, which has been associated
with increased tissue damage (Maritim et al.
2003) and enhanced smooth muscle tone
(Stocker and Keaney 2004). They also have
endothelial inﬂammation and hypercoagulabil-
ity (Beckman et al. 2002).
PM has been shown to cause adverse
health effects through many of these same
mechanisms. The exposure to ambient PM
might lead to pulmonary as well as systemic
inflammation (Pope and Dockery 2006).
Moreover, PM or PM components have been
found to be translocated from the lung into
the vascular system (Nemmar et al. 2002,
2004). Thus, diabetes and the vascular effects
of PM may share common pathways and
interact to enhance responsiveness of diabetic
patients to air pollutants. Of note, PM has
been shown to induce oxidative stress
(Donaldson et al. 2005), and this excessive
generation of free radicals may also affect the
antioxidant capacity in the endothelium and
lead to further synergistic interaction on the
generation of reactive oxygen species after PM
exposure. However, this argument must be
approached with the caveat that PM2.5 proba-
bly does not adequately represent the toxicity
of ultraﬁne PM to the circulatory system.
Endothelial function and PM. Other
studies have also examined the association of
PM and endothelial cell function. Inhalation of
diesel exhaust has been shown to impair vaso-
motor responses to endothelium-dependent
and -independent vasodilators 6 hr after expo-
sure (Mills et al. 2005). In a French study
(Briet et al. 2007) with 40 young healthy male
volunteers devoid of cardiovascular risk fac-
tors, exposure to gaseous and PM pollutants
led to a significant alteration in endothelial
function in large and small arteries, respec-
tively. Brook et al. (2002) found a signiﬁcantly
decreased basal brachial artery diameter in
individuals exposed to concentrated ambient
air PM plus ozone for 2 hr. However, in con-
trast to our ﬁndings, they observed no altered
FMD in those individuals. This difference
might either be explained by the study popula-
tion (normal vs. diabetes), duration of expo-
sure (2 hr vs. 24 hr), or the presence of ozone
in the study of Brook et al. Healthy inter-
collegiate athletes showed decreased FMD
when exposed to ambient PM while exercising
(Rundell et al. 2007). O’Neill et al. (2005)
Air pollution and endothelial function in diabetic individuals
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Figure 2. Effect modiﬁcation of FMD by markers representing diabetic disease control or medication use. The estimates are given as percent change of mean
FMD level based on a 10-μg/m3 increment of PM2.5; error bars indicate 95% CIs. p-Values indicate the signiﬁcance of the interaction term.
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Figure 3. Effect modiﬁcation of FMD (A) and SAEI (B) by the GSTM1 genotype. The estimates are given as percent change of mean FMD level based on a 10-μg/m3
increment of PM2.5; error bars indicate 95% CIs. p-Values indicate the signiﬁcance of the interaction term.
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A Bstudied 270 Greater Boston, Massachusetts,
residents, including 182 individuals with
type 2 diabetes. In this subgroup, they found
the strongest decrease of FMD associated with
a 6-day moving-average exposure of sulfates
and black carbon; the effect estimates for
PM2.5 and particle number count were a little
smaller and not statistically significant. In
addition, several studies on passive smoking
reported a decrease in endothelial function
after exposure to environmental tobacco
smoke (Holay et al. 2004; Howard and
Wagenknecht 1999; Kato et al. 2006).
Impaired endothelium-dependent vaso-
dilatation could be caused by decreased pro-
duction of NO by endothelial cells or by
PM-induced changes in smooth muscle cells
lining the vessel. To distinguish between these
two possibilities, participants in our study
were given nitroglycerin, an NO donor, as
part of the vascular imaging procedure. There
was no signiﬁcant association at lag 0 between
PM and NTGMD, suggesting that the change
in FMD at lag 0 is best explained by an alter-
ation in endothelial cell NO production rather
than some other effect in the vascular smooth
muscle cells. Several studies have shown an
increased risk for cardiovascular events in peo-
ple in whom endothelial cell production of
NO is chronically reduced. There are also
reports that a sudden loss in endothelial activ-
ity could promote cardiac ischemia or trigger
instability of susceptible plaques in individuals
with ﬂow-limiting obstructive lesions (Muller
et al. 1994). An alternative putative measure
of endothelial function in a subsample of our
study showed increased systemic arterial stiff-
ness with increasing PM2.5. Reductions in
LAEI increase with age, whereas reductions in
SAEI are observed in patients at risk for coro-
nary heart disease and independently predict
risk for cardiovascular events (Grey et al.
2003). Stiffer vessels produce an earlier return
of the reﬂected wave from vascular branching
points to the ascending aorta. This phenome-
non increases left ventricular afterload on the
heart and leads to reduced coronary perfusion
(Weber et al. 2004). Endothelial dysfunction
and increased arterial stiffness commonly
coexist in patients at increased risk of cardio-
vascular disease such as those with diabetes
(De Vriese et al. 2000). This leads to the
hypothesis that cardiovascular risk factors may
exert their detrimental effects on arterial stiff-
ness through endothelial dysfunction and that
endothelial factors such as NO may contribute
a functional component to arterial stiffness.
Further studies are required to fully deﬁne the
link between endothelial function and arterial
stiffness. However, most studies suggest that
endothelium dysfunction might be one poten-
tial mechanism underlying alterations on the
elasticity of atherosclerotic vessels, supporting
our findings about immediate changes in
endothelial function (FMD) and delayed
changes in arterial stiffness (pulse waveform
measures) in association with increasing PM.
Effect modiﬁcation. In our study, markers
of insulin resistance such as obesity and poor
glycemic control as reflected by increased
HbA1c and adiponectin were associated with
response to PM2.5. Adiponectin is an abun-
dant circulating adipocyte-derived peptide,
has insulin-sensitizing, anti-inflammatory,
and cardioprotective properties (including
endothelial function), and is inversely corre-
lated with BMI (Tan et al. 2004). Low
adiponectin levels are associated with an
increased risk of developing type 2 diabetes in
healthy individuals (Spranger et al. 2003).
The observed effect modification is in
agreement with O’Neill et al. (2007), who
demonstrated that elevated BMI in diabetics
was also associated with increased responsive-
ness to PM. However, we found the strongest
effect modiﬁcation for MPO, an enzyme that
binds to the vessel wall and depletes vascular
NO bioavailability (Rudolph et al. 2006).
Activated polymorphonuclear neutrophils, an
early event in unstable coronary disease, liber-
ate MPO, which has oxidative power.
Therefore, it is conceivable that on days with
elevated PM levels, there is increased MPO
production, resulting in less NO production
from endothelial cells and thus a decrease in
endothelial function.
We also observed that participants with the
null genotype for GSTM1 had larger decre-
ments in FMD associated with PM exposure.
GSTM1 is a phase II enzyme that can scavenge
oxygen free radicals, metabolize reactive oxygen
species, and detoxify xenobiotics present in
PM. Therefore, it is plausible that people with
a GSTM1 deletion are not able to handle
oxidative stress well and may be more respon-
sive to agents such as PM that increase oxida-
tive stress. Asthmatic children with the
GSTM1 null genotype appear to be more sus-
ceptible when exposed to ozone than are those
with the wild-type allele (Romieu et al. 2004,
2006). Gilliland et al. (2004) showed that in
the presence of diesel exhaust particles, the
enhancement of allergic responses was largest
in participants with GSTM1 null genotype.
Moreover, Schwartz et al. (2005) reported a
stronger association between autonomic con-
trol of the heart and PM in people with the
null GSTM1 allele.
The trends found for GSTP1, also a phase
II enzyme and a crucial factor in determining
the sensitivity of cells to toxic chemicals and
products of oxidative stress, point in the same
direction as the GSTM1 results. The GSTP1
gene product provides > 90% of the GST fam-
ily activity in the lung; enhancement of the
allergic response by secondhand tobacco smoke
was larger in allergen-sensitive individuals with
the GSTP1 wild type (Gilliland et al. 2006).
However, in the present study, an additive
trend of the variant showed more impaired
FMD with every copy of the variant. Salam
et al. (2007) similarly found that the variant
contributed to the occurrence of childhood
asthma and increase of asthma susceptibility in
association with exposures to major roads. Also
Gilliland et al. (2002) showed slower lung
function growth in children who were
homozygous for the variant.
Polymorphisms of the HFE gene have
been found to blunt the effect of particles on
cardiac autonomic function in the Normative
Aging Study. Park et al. (2006) observed
PM2.5 effects only in individuals with the
wild-type of the HFE genotype; a single copy
of the variant blunted the relationship. The
protein product of the HFE gene modulates
iron binding and storage (Hanson et al. 2001)
from pulmonary sources. The two analyzed
polymorphisms are associated with increased
iron uptake (Feder et al. 1998) and may mod-
ify the effect of metal-rich particles on the car-
diovascular system. However, in contrast to
results of Feder et al. (1998), we found that
diabetics with one copy of the variant (no one
had two copies of the variant) had a trend
toward stronger impairment of endothelial
reactivity than did patients with the wild type.
Strengths and limitations. One strength
of the present study is the good compliance of
the volunteers who all came four times for a
clinical visit. However, the design might not
be perfect for markers with longer half-lives,
such as ﬁbrinogen, because it implies autocor-
relation between the data from consecutive
days. This should not be a major inﬂuence on
markers with shorter half-lives, such as meas-
ures of endothelial function. Daily variations
could have an influence on the health out-
comes, but models were adjusted for day of
week if AIC proved it to be necessary.
A limitation of the study is the small
number of subjects studied. Although suffi-
cient to observe associations between PM and
endothelial cell function in the whole popula-
tion, power was too low to detect changes in
subsets such as seen with some of the genetic
polymorphisms.
Moreover, we have to acknowledge the
possibility that the reported effect estimates
might be modiﬁed by copollutants that were
not measured. Because of space limitations,
data on subject-specific PM monitoring and
particle components in association with
endothelial function will be presented in a
future publication.
Another strength of this study is the investi-
gation of air pollution effects in a particularly
vulnerable subgroup. This population is
thought to be especially vulnerable to the acute
effects of particles due to chronic inﬂammation,
imbalances in vasoactive processes, vascular
remodeling, and an increased potential for
Schneider et al.
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therefore cannot be generalized to the whole
population. Of course, who is susceptible
depends on the specific end point evaluated
and the level and length of exposure. Although
the results might not be generalizable to all
diabetics, we believe they are generalizable to
the vast majority, including those at risk for
cardiac events.
Comparing two different aspects of
endothelial function is certainly a strength of
this study, especially examining the correlation
between the two measurements and the lag
structure in association with PM response. The
use of pulse waveform analysis may therefore
help to estimate the association between PM2.5
exposure with NO-independent pathways (not
related to FMD, e.g., the one mediated by
endothelin) compared with NO-mediated
mechanisms of vascular injury (related to
FMD). This aspect is important because ani-
mal data support that particle-induced vaso-
constriction is mediated by endothelin release
(Bouthillier et al. 1998). Moreover, the com-
parison of changes in FMD and NTGMD
gave more insight into the pathophysiologic
process than do existing studies on PM effects
on endothelial dysfunction.
In this study, we used daily PM2.5 mass
values from a state monitoring station located
27 miles away from the U.S. EPA HSF. In
addition, we obtained PM2.5 values on the
HSF rooftop. There was a strong correlation
between these two sets of measurements, sug-
gesting that we were accurately assessing
ambient exposure of the study participants.
However, our study shows the general limita-
tion of accurately measuring exposure of par-
ticipants as all panel studies with a similar
design. The design and the limited number of
participant also made it difficult to test for
seasonal differences in the detected associa-
tions. All the subjects lived within a 30-mile
radius of Chapel Hill, and no one had any
unusual exposure to air pollution because of
residence or occupation. Of course, there
could be variable exposure to traffic as the
participants commuted to work and to the
U.S. EPA HSF, which is difﬁcult to capture.
Conclusions
Our study showed an immediate association
between altered endothelial function and PM
in persons with type 2 diabetes. Markers for
insulin resistance (BMI, HbA1c, adiponectin)
were associated with enhanced effects of PM
on endothelial function. Individuals with
greater oxidative potential were more suscepti-
ble to PM exposure. These data suggest that
the adverse cardiovascular consequences of air
pollution in patients with diabetes may be
mediated, at least in part, by impaired function
of the vascular endothelium, and that people
with diabetes are an especially sensitive
subpopulation that needs to be protected from
the harmful effects of air pollution. The role
of airborne PM in the pathophysiology of
insulin resistance, diabetes, and their compli-
cations requires further study but does suggest
opportunities to promote better health.
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